;Amhr2 tm3(cre)Bhr/ϩ mice, which lack the PI3K signaling antagonist gene Pten in myometrial and stromal/decidual cells. Primiparous Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mice were found to be subfertile because of increased fetal mortality at e11.5. Histopathological analyses revealed a failure of decidual regression in these mice, accompanied by reduced or absent invasion of fetal trophoblast glycogen cells and giant cells, abnormal development of the placental labyrinth, and frequent apparent intrauterine fetal growth restriction. Unexpectedly, the loss of phosphate and tensin homolog deleted on chromosome 10 (PTEN) expression in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ decidual cells was not accompanied by a detectable increase in AKT phosphorylation or altered expression or activation of PI3K/AKT downstream effectors such as mammalian target of rapamycin or glycogen synthase kinase-3␤. Terminal deoxynucleotidyl transferase-mediated nick end labeling and bromodeoxyuridine incorporation analyses attributed to the lack of decidual regression mainly to decreased apoptosis in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ decidual cells, rather than to increased proliferation. Remodeling of the maternal vasculature was delayed in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ uteri at e11.5, as evidenced by persistence of vascular smooth muscle and decreased infiltration of uterine natural killer cells. In addition, thickening of the myometrium and disorganization of the muscle fibers were observed before and throughout gestation. Almost all Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice failed to carry a second litter to term, apparently attributable to endometrial hyperplasia and uterine infections. Together, these data demonstrate novel roles of PTEN in the mammalian uterus and its requirement for proper trophoblast invasion and decidual regression.
phosphate and tensin homolog deleted on chromosome 10; AKT; decidua; myometrium; conditional gene targeting THE INVASION OF THE MATERNAL decidua by placental trophoblast cells is a defining step in the implantation process. After mediating the attachment of the placenta to the uterus, invading trophoblast cells participate in a variety of physiological processes that are critical for the maintenance of pregnancy, including the regulation of maternal vascular development and the secretion of several cytokines and hormones that modulate maternal immune, metabolic, and endocrine functions (21) . Indeed, defects in trophoblast invasion are involved in the etiology of a number of important gestational pathologies, such as spontaneous miscarriage (15, 18) , intrauterine growth restriction (5, 25) , and preeclampsia (22) . In humans, one of the most important functions of trophoblast cells is the mediation of the transformation or conversion of the maternal spiral arteries. By this process, the endovascular cytotrophoblast cells invade the spiral arteries, displacing and replacing endothelial cells and degrading the muscular and elastic tissue of the vessel wall (10, 14, 22) . This results in the formation of dilated vessels that are required for adequate uteroplacental circulation and fetal development. An analogous arterial transformation process occurs in the rodent placenta (which is also hemochorial) although available evidence indicates that uterine natural killer cells (uNKs) may be its principal mediator, rather than trophoblast cells (9, 13) . Nonetheless, trophoblast cells are thought to play important roles in regulating maternal vascular development and function in rodents, notably by producing factors that regulate maternal blood flow and angiogenesis, and they are capable of endovascular invasion of spiral arteries as well (8) .
Much research has been devoted to identifying the mechanisms by which invading trophoblast cells degrade maternal tissues (22) . However, comparatively little attention has been paid to the role of the maternal decidua, which, particularly in rodents, must regress in concert with the advancing trophoblast during the invasion process, and this is widely believed to depend on a complex interplay between the trophoblast and decidual cell types (10, 22) . Although the signaling mechanisms and pathways involved in decidual regression remain poorly defined, several lines of evidence indicate that the phosphatidylinositol 3-kinase (PI3K)/AKT pathway is a major regulator of decidual cell proliferation and survival. For example, endothelin-1 of endometrial epithelial origin is thought to regulate the proliferation of uterine stromal cells in a paracrine manner via the PI3K/AKT pathway (16) . Additionally, prolactin and insulin-like growth factor (IGF)-1 can mediate decidual cell survival and act by activating PI3K/AKT signaling (29, 30) . Conversely, transforming growth factor-␤1 has been shown to promote apoptosis in cultured decidual cells, and its mechanism of action involves the inhibition of AKT phosphorylation (26) . Thus downregulation of PI3K/AKT signaling may be necessary for decidual regression, acting as a permissive factor for subsequent trophoblast invasion.
The Pten gene encodes a lipid phosphatase that acts as an antagonist of the PI3K/AKT signaling pathway by dephosphorylating phosphatidylinositol (3,4,5)-trisphosphate and thereby inhibiting phosphoinositide-dependent kinase activity (6) . To study the role of the PI3K/AKT pathway in ovarian granulosa cells, we recently devised a conditional gene-targeting strategy to constitutively derepress the pathway by inactivation of Pten. Mice bearing a floxed Pten allele (Pten tm1Hwu ) (12) were mated to the Amhr2 tm3(cre)Bhr strain (in which the Cre transgene is knocked in to the Amhr2 locus) (17) , and the resulting offspring were analyzed for ovarian phenotypic anomalies. Surprisingly, the vast majority of Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice had morphologically and physiologically normal ovaries, which was ultimately attributed to inefficient recombination of the Pten tm1Hwu alleles, resulting in the loss of Pten only in rare granulosa cells (19) . Despite this, Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mice were infertile and either failed to carry pregnancies to term or had small litters attributable to increased fetal mortality after e9.5. Recent studies have indicated that the Amhr2 tm3(cre)Bhr allele drives Cre expression in a wider array of tissues than originally thought, including the developing uterine myometrium (1, 23, 28). We therefore proposed that infertility in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice could be of extraovarian origin and that this model could be used to define novel roles for phosphate and tensin homolog deleted on chromosome 10 (PTEN) and PI3K/AKT signaling in uterine physiology and pregnancy (19) . In this study, we sought to demonstrate that infertility in Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mice is attributable to a uterine defect and to define the cellular and molecular processes that are disrupted by the loss of uterine PTEN expression.
MATERIALS AND METHODS
Animals, genotype analyses, treatments and progesterone measurements. Genetically modified animals were derived by selective breeding of previously described Pten tm1Hwu/tm1Hwu and Amhr2 tm3(cre)Bhr/ϩ parental strains (12, 17) and maintained on a mixed C57/Bl(6) ϫ 129Sv genetic background. Genotyping analyses were performed by PCR on DNA obtained from tail biopsies as previously described (19) . Timed matings were done by breeding either Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ or Pten tm1Hwu/tm1Hwu females with C57/Bl(6) males, and the morning of the detection a vaginal plug was designated d0.5 pc (postcoitum). Cell proliferation in uteri of Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ and Pten tm1Hwu/tm1Hwu mice was assessed by bromodeoxyuridine (BrdU) incorporation analyses. Mice were injected intraperitoneally with 150 mg/kg body wt BrdU (Sigma, St. Louis, MO) and euthanized 3 h after injection. For serum progesterone measurements, blood samples were collected by cardiac puncture under anesthesia prior to euthanasia. Progesterone radioimmunoassays were done on serum samples at the Ligand Assay and Analysis Core within the Center for Research in Reproduction at the University of Virginia. Intra-and interassay coefficients of variability were 4.4% and 7.4%, respectively. All animal procedures were approved by the Institutional Animal Care and Use Committee and conformed to the USPHS Policy on Humane Care and Use of Laboratory Animals.
Histochemistry and immunohistochemistry. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded, 7-m tissue sections using VectaStain Elite avidin-biotin complex method kits (Vector Laboratories, Burlingame, CA) as directed by the manufacturer, except incubation with primary antibodies was performed overnight at 4°C. The Vector M.O.M. Basic Kit was used whenever a mouse-derived primary antibody was applied to mouse tissues. For detection of smooth muscle actin binding protein, transgelin (TAGLN), the slides were further treated with 20 g/ml of proteinase K (Invitrogen, Burlington, ON, Canada) in PBS for 5 min at room temperature following heat-induced antigen retrieval in 10 mM citrate buffer.
Sections were probed with primary antibodies against PTEN, phospho-(Ser473)-AKT, phospho-(Ser2448)-mammalian target of rapamycin (mTOR) (catalog nos. 9559, 4051, and 2976, respectively; Cell Signaling Technology, Danvers, MA), TAGLN/SM 22-␣ (catalog no. ab10135; Abcam, Cambridge, MA), pan cytokeratin (catalog no. sc-15367; Santa Cruz Biotechnology, Santa Cruz, CA), S100A4, ␣-smooth muscle actin (ACTA2) (catalog nos. HPA007973 and A-2547, respectively; Sigma Aldrich, Oakridge, ON, Canada), or BrdU (clone Bu20a; Dako, Carpinteria, CA) using the manufacturers' suggested conditions. For all experiments, control sections were probed with nonspecific IgG from the relevant species (10 g/ml final concentration), which failed to generate signal in all cases. Staining was performed using the 3,3=-diaminobenzidine (DAB) peroxidase substrate kit (Vector Laboratories) as directed, and slides were lightly counterstained with hematoxylin before mounting.
Dolichos biflorus agglutinin lectin histochemistry methods for the detection of uNKs were similar to those described above for immunohistochemistry, except antigen retrieval was omitted and secondary antibody was not needed. Instead, sections were quenched for endogenous peroxidase activity using 1% H 2O2 in PBS, washed, and blocked for 1 h with 10% horse serum ϩ 10% BSA in PBS with 0.1% Tween 20. Tissues were subsequently probed with 50 g/ml biotinylated Dolichos biflorus agglutinin (Sigma) in 2% horse serum ϩ 2% BSA in PBS for 1 h at room temperature. Detection was performed using the streptavidin-horseradish peroxidase complex as described above. Sections were stained with hematoxylin before mounting.
GLB1 and alkaline phosphatase assays. Uteri from d11.5 pc pregnant Gt(ROSA)26Sor tm1Sho/ϩ and Gt(ROSA)26Sor
mice were stained for ␤-galactosidase (GLB1) activity using the Chemicon International Stain for ␤-Galactosidase Expression in Tissue kit as directed by the manufacturer (Bioscience Research Reagents, Temecula, CA). Stained uteri were postfixed in formalin overnight, embedded in paraffin, sectioned, and counterstained with eosin. For alkaline phosphatase detection, tissues were frozen in optimal cutting temperature compound (Sakura Finetek, Torrance, CA) at Ϫ80°C, 5-m sections were prepared, and the slides were postfixed in 0.2% gluteraldehyde in cold PBS for 10 min, followed by three washes in PBS of 5 min each. Slides were then washed twice in alkaline phosphatase buffer (100 mM Tris·HCl, pH 9.5, 100 mM NaCl, 10 mM MgCl2) for 5 min. The slides were overlayed with nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (NBT/ BCIP) stain (100 mM Tris·HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40, 337 g/ml NBT, 175 g/ml BCIP) at 37°C for 4 min, washed in PBS three times for 5 min, and counterstained with nuclear fast red before mounting.
TUNEL. Sections were deparaffinized and treated with 10 g/ml proteinase K in PBS for 10 min, followed by brief washes with deionized water and PBS. Endogenous peroxidase was quenched in 3% H2O2 in methanol for 30 min, and slides were washed in PBS and preequilibriated for 10 min at room temperature in a solution of 1ϫ One-Phor-All PLUS buffer (GE Healthcare, Baie d'Urfe, QC, Canada) supplemented with 0.1% Triton X-100 (Sigma, Oakville, ON, Canada). Terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) reaction mixture was prepared with the following final concentrations, diluted in 0.1% Triton X-100: 1ϫ One-Phor-All PLUS buffer, 10 M biotin-16-dUTP (Enzo Life Sciences, Farmingdale, NY), 1 M dATP (Fermentas, Burlington, ON, Canada), and 20 IU of terminal deoxynucleotidyl transferase, FPLCpure enzyme (GE Healthcare). Sections were incubated with the TUNEL reaction mixture in a humidified chamber for 90 min at 37°C and subsequently washed with PBS. Streptavidin-horseradish peroxidase reagent (Vector Laboratories) was used for detection of incorporated biotinylated nucleotides, and the color reaction was developed using DAB substrate. Sections were counterstained with hematoxylin before mounting.
Immunoblotting. Proteins were extracted from uterine tissues using T-PER tissue protein extraction reagent (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer's instructions, and all protein sample concentrations were quantified using the Bradford method. Samples (25 g) were resolved on 7-12% SDS-polyacrylamide gels and transferred to Hybond-P PVDF membrane (GE Amersham, Piscataway, NJ). Blots were probed with antibodies against AKT, Forkhead box-containing protein-O1 (FOX01), X-linked inhibitory apoptotic protein (XIAP), Bcl-2/Bcl-XL antagonist causing cell death (BAD), mTOR, phospho-(Ser2448)-mTOR, glycogen synthase kinase (GSK)3␤, phospho-(Ser9)-GSK3␤ (catalog nos. 9272, 2880, 2042, 9292, 2983, 2971, 9315, and 9323, respectively, Cell Signaling), PTEN, phospho-(Ser473)-AKT (described above), or ␤-actin (catalog no. sc-47778; Santa Cruz Biotechnology) as directed by the manufacturer. Following incubation with horseradish peroxidase-conjugated secondary antibody (GE Amersham), the protein bands were visualized by chemiluminescence using ECL Plus Western Blotting Detection Reagents (GE Amersham) and High-Performance Chemiluminescence film (GE Amersham). Relative signal intensities were quantified using a Kodak Image Station 440CF and Kodak 1D v.3.6.5 software (Eastman Kodak, Rochester, NY).
Stereomicroscopic measurements. Myometrial thickness was measured in nonpregnant, d9.5, d11.5, and d14.5 pc Pten tm1Hwu/tm1Hwu (n ϭ 3, 4, 5, and 4, respectively) and Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ (n ϭ 3, 4, 4, and 4, respectively) mice. Transverse sections were cut from random locations in both uterine horns in nonpregnant uteri and through the thickest part of concepti in pregnant animals. Briefly, 3-20 hematoxalin and eosin-stained sections per uterus were examined at low magnification. To ensure randomness of sampling, sections were overlaid with a circular grid, and myometrial thickness measurements were taken at the four cardinal points (N, S, E, W). The thickness of the longitudinal and circular muscle layers were measured separately, and the measurements were added to obtain the total thickness of the myometrium. The final myometrial thickness value for a given animal was the average of all measurements taken from all sections (i.e., 12-80 measurements/animal). Measurements and photomicrographs were taken using a Zeiss Imager M.1 microscope, using AxioVision 4.6 software (Carl Zeiss, Jena, Germany). The same instruments were used to measure maternal decidual surface area for comparisons between genotypes, as well as to permit the calculation of relative densities of uNK and TUNELpositive and BrdU-positive cells.
Statistical methods. Effects of genotype on litter size, progesterone concentrations, myometrial thickness, uNK cells/surface, TUNELpositive cells/surface, BrdU-positive cells/surface, maternal decidua surface, and immunoblot band intensities were analyzed by unpaired, two-tailed Student's t-tests. P values Ͻ0.05 were considered statistically significant. Data are presented as means Ϯ SE. Analyses were performed using Prism 4.0a software (GraphPad Software, San Diego, CA). and Pten tm1Hwu/tm1Hwu females had comparable numbers of concepti at d9.5 pc (19) , suggesting that ovulation and implantation were normal and that infertility could be attributable to fetal loss after e9.5. We therefore examined Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ and control pregnancies at d11.5 pc and found comparable numbers of fetuses; however, fetal viability was ϳ30% lower in the Pten tm1Hwu/tm1Hwu ;Amhr2 (Table 2) . Although histological analyses of the corpora lutea of Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice revealed no anomalies at d11.5 and d14.5 pc (data not shown), we could not exclude that fetal loss could be attributable to altered progesterone production. We therefore compared serum progesterone levels in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ and control mice throughout gestation and failed to detect differences between the two groups ( tm1Sho reporter strain, which drives GLB1 expression in all cell types with Cre activity. Gt(ROSA)26Sor tm1Sho/ϩ ; Amhr2 tm3(cre)Bhr/ϩ mice were found to have high levels of GLB1 in the myometrium (Fig. 1B) , and lesser levels of staining were observed in the uterine stroma (data not shown), maternal decidua (Fig. 1C) , and in the walls of many decidual blood vessels (Fig. 1D) . These results confirm and expand upon the ; Amhr2 tm3(cre)Bhr/ϩ mice revealed nearly complete abrogation of PTEN expression in the myometrium and stromal compartments, as well as in the maternal decidual cells of pregnant Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ uteri (Fig. 2, A-D) . Loss of PTEN was also observed in a small proportion of endometrial epithelial cells (Fig. 2B, inset) , mainly in the glandular epithelium. Epithelial cells lacking PTEN appeared hypertrophic, hyperplastic, and disorganized. Loss of PTEN expression was confirmed and quantified by immunoblotting, which demonstrated an average 4.03-fold lower level of PTEN in Pten
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;Amhr2 tm3(cre)Bhr/ϩ nonpregnant and d11.5 pregnant uterine wall samples (Fig. 3) . This likely represented an underestimation of the reduction of PTEN expression that occurred in decidual and myometrial cells, as the uterine wall samples included cell types not targeted by the Amhr2 tm3(cre)Bhr/ϩ allele, including endothelial and epithelial cells (Fig. 2, B and D) .
To evaluate the consequences of loss of PTEN expression on the activity of the downstream signaling effector AKT, phosphoAKT expression was studied by immunohistochemistry and immunoblotting. Unexpectedly, no obvious differences could be detected between Pten tm1Hwu/tm1Hwu and Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ pregnant and nonpregnant uteri in any cell type (Fig. 2, E and F) . This result was quantitatively confirmed by immunoblotting (Fig. 3) , which failed to detect significant differences in AKT phosphorylation according to genotype or pregnancy status (P Ͼ 0.05). Uterine tissue surrounding viable or dying fetuses also showed comparable levels of phospho-AKT expression (Fig. 3) . Likewise, immunohistochemical and immunoblotting analyses failed to detect differences in the expression or phosphorylation levels of the AKT downstream effectors mTOR and GSK3␤ (Figs. 2, G and H, and 3 and data not shown, P Ͼ 0.05). Immunoblotting analyses of additional AKT signaling effectors either revealed no differences between Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ uterine protein extracts and controls (XIAP) or were undetectable in our samples (FOXO1a, BAD) (not shown).
Pten tm1Hwu/tm1Hwu
;Amhr2 tm3(cre)Bhr/ϩ mice have fetal trophoblast invasion and maternal decidual regression defects. To study the consequences of PTEN deficiency in the uterus, comparative histopathological analyses were conducted on concepti from Pten tm1Hwu/tm1Hwu and Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mice at d9.5, d11.5, and d14.5 pc. By d11.5 pc, the placental labyrinth was thin and underdeveloped in most Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ concepti, and trophoblast migration appeared restricted by an abnormally thick maternal decidua (Fig. 4, A and B cidua were abnormal in appearance, notably featuring many mitotic figures at d11.5 pc, little evidence of apoptosis, and many cells with unusually abundant cytoplasm, particularly near the trophoblast invasion front. Nonetheless, alkaline phosphatase staining confirmed them to be decidual cells (Fig. 4, E  and F) .
BrdU incorporation assays showed regions containing abnormally high numbers of proliferating decidual cells in proximity to the invading trophoblasts in Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ decidua that were not found in Pten tm1Hwu/tm1Hwu controls (Fig. 4, G and H) . Quantitative analyses of proliferating decidual cells throughout the mesometrial maternal decidua showed 41.9% more BrdU-positive cells in samples from Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice although this was not found to be statistically significant (Table 4 , P ϭ 0.1). Conversely, TUNEL assays showed a significant, nearly ninefold decrease in apoptotic decidual cells in Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mice relative to controls (Table 4 , Fig. 4 (Fig. 5, A and B ; Amhr2 tm3(cre)Bhr/ϩ uteri suggested an increase in the thickness of the myometrium (Fig. 6, A and B) . To confirm this finding in a quantitative manner, we measured myometrial thickness in nonpregnant and pregnant uteri throughout gestation. Results confirmed that increased myometrial thickness occurs in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ uteri before and throughout gestation, with total thickness of the longitudinal and circular layers being nearly twice that of Pten tm1Hwu/tm1Hwu controls at all time points examined (Fig. 6C) . Interestingly, TAGLN immunostaining suggested a lower overall level of TAGLN expression in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ myometrial cells, and the muscle fibers frequently seemed less abundant and disorganized despite the overall greater thickness of the myometrial layer (Fig. 6, D and E) . ;Amhr2 tm3(cre)Bhr/ϩ females kept in breeding pairs, only one brought a gestation to term but died because of an inability to completely expel the first fetus. In this female, a second completely developed pup was found in the uterus, along with six additional decomposing and partially resorbed pups. Additional timed mating experiments were then performed with Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ females that had previously had one litter. Copulatory plugs were observed in all cases, and females were euthanized at d9.5, 21.5, 22.5, 42.5, 49.5, 61.5, 112.5, and 119.5 pc, and the reproductive tracts were submitted for histopathological analyses. All uteri showed varying degrees of hyperplasia of both the uterine and glandular epithelia (Fig. 7A) . At d9.5, although all uteri examined showed evidence of implantation at several sites and residual maternal decidua (Fig. 7B) , no viable fetuses were found. At d22.5 pc (i.e., 2-3 days after expected parturition), necrotic decidua, labyrinth, and fetal membranes were frequently identified (Fig. 7C) , along with transmural pyometritis and edema in the endometrial stroma (data not shown). At d42.5, a persistent mummified fetus was identified in one Pten tm1Hwu/tm1Hwu
;Amhr2 tm3(cre)Bhr/ϩ female (data not shown), whereas others showed severe mucometra (Fig. 7D) . In addition, evidence of endometrial fibrosis was found at d112.5 and d119.45 pc (not shown). Together, these data indicate that the subfertility observed in primiparous Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice progressed to sterility in the subsequent gestation, apparently because of epithelial hyperplasia and other uterine anomalies leading to failure of implanted fetuses to develop to term. and Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ uterine wall samples from nonpregnant mice and at d11.5 pc. In pregnant mice, uterine tissues surrounding healthy and nonviable fetuses were analyzed separately. Densitometric analyses were performed using n ϭ 4 samples per pregnancy/ viability status and per genotype and normalized to corresponding ␤-actin (ACTB) loading control values before statistical analyses. Comparisons between genotypes for each pregnancy/viability status failed to show statistically significant differences for any of the proteins examined, except for PTEN as mentioned in the text. Arrows indicate bands of interest. GSK, glycogen synthase kinase.
DISCUSSION
Successful implantation is dependent on a complex interplay between the invading trophoblast and the maternal tissue. Whereas some molecular mechanisms by which trophoblast cells invade the uterine tissue have been elucidated (2, 3, 22) , the process by which the decidua permits and regulates this invasion is not well understood. Several studies have shown that different signaling molecules can affect proliferation and apoptosis of uterine stromal and decidual cells in vitro by signaling via the PI3K/AKT pathway (16, 20, 26, 29, 30, 32) ; however, the physiological importance of PI3K/AKT signaling during decidualization and decidual regression has not been es- tablished. In this report, we have shown that Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ maternal decidual cells had vastly reduced PTEN expression, which was associated with greatly reduced apoptosis. This resulted in reduced trophoblast giant cell and glycogen cell migration, poor development of the placental labyrinth, and apparent fetal growth restriction. This demonstrates a previously unknown role for PTEN in the regulation of decidual regression and trophoblast invasion and suggests that PI3K/AKT signaling activity must be repressed in decidual cells at the fetal-maternal interface to permit these processes to occur normally. If the latter holds true, further studies will be required to identify 1) the physiological agonists and antagonists of PI3K/AKT signaling in decidual cells, 2) which cells produce these factors, 3) how potential PI3K/AKT agonists and antagonists are regulated, and 4) the mechanisms by which these factors ultimately regulate decidual cell apoptosis. Unexpectedly, however, we failed to identify an increase in phospho-AKT expression in response to loss of PTEN in the Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ uterus and also failed to identify differences in the expression or activation of several downstream AKT signaling effectors commonly involved in the regulation of cell proliferation and apoptosis. This may indicate that, in decidual cells, PTEN promotes apoptosis via signaling mechanisms unrelated to the canonical PI3K/AKT pathway, as may also occur in other cell types (4) . On the other hand, a subtle or transient deficiency of repression of PI3K/AKT signaling at the fetal-maternal interface in Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ decidua could easily have gone undetected in our immunohistochemistry and immunoblotting experiments. Further analyses will therefore be required to confirm PTEN activity as an inhibitor of canonical PI3K/AKT signaling in this context.
In this study, we also identified a transient defect in the remodeling of the maternal vasculature in the pregnant Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ uterus, which appeared to be related to decreased infiltration of uNK cells at d11.5 pc. Uterine NK cells are thought to be recruited from the peripheral blood in response to chemokines secreted by decidual, endometrial, and trophoblast cells (24) , causing their numbers to peak between d10.5 and d14.5 pc in the maternal compartment of the mouse placenta (7, 9) . The relative lack of uNK cells in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ uteri may therefore be the result of altered secretion of chemoattractants by the decidua, possibly as a result of altered PI3K/AKT signaling, causing chemokine genes to be abnormally expressed. However, several other mechanisms could be involved; for example, Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ decidual cells may not express the proper complement of cell surface molecules to permit optimal uNK cell adhesion and migration. Alternatively, inhibition of trophoblast migration may prevent trophoblast chemokine production or impede proper secretion or delivery of these signaling molecules. Thus the Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ model may provide a useful model to study uNK chemotaxis and may aid in the identification of the cell types (A and B) and Dolichos biflorus agglutinin lectin analyses (C, D) on uteri from d11.5 pc mice, showing decreased numbers of uNK cells and poorly transformed blood vessels (arrowheads, also shown at higher magnification in inset) in Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ maternal decidua compared with well-transformed blood vessels (arrows, also shown at higher magnification in the inset) in the Pten tm1Hwu/tm1Hwu controls. Original magnification, ϫ100 (A and B), ϫ200 (C and D), ϫ1,000 (A and B, inset). and chemokines critical for uNK cells infiltration and subsequent maternal vascular remodeling during placentation.
The exact cause of fetal death in Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mice remains enigmatic. At primiparity, the loss of some pups could be attributable to reduced trophoblast migration, poor labyrinth development, and delayed transformation of the maternal blood vessels. Such defects resulted in shallow implantation, poor fetal-maternal circulation, inadequate embryonic development, and ultimately death. However, histopathological analyses of Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ concepti suggested that the extent of these problems, although entirely compatible with intrauterine growth restriction, did not appear severe enough to cause fetal death. A possible explanation may be related to the observed uterine glandular epithelial cell hyperplasia, which was infrequently observed in virgin Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice but became a common feature throughout the uterus by the second pregnancy. Epithelial hyperplasia has previously been correlated with the loss of PTEN expression. A recent study reported that conditional deletion of Pten in the uterine epithelium using a transgenic mouse strain in which Cre expression is driven by the progesterone receptor promoter resulted in severe epithelial hyperplasia that later developed into endometrial cancer (11) . Although our analyses of Gt(ROSA)26Sor tm1Sho/ϩ ; Amhr2 tm3(cre)Bhr/ϩ failed to detect Cre activity in the uterine epithelium, Cre-mediated recombination of the floxed Pten alleles in Pten ; Amhr2 tm3(cre)Bhr/ϩ uteri is suggestive of altered glandular secretions and compromised local immune functions, both of which are likely contributors to the development of sterility in Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice. Another important finding reported in the present study is the increased thickness of the myometrium observed in pregnant and nonpregnant Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ mice. Although histopathological analyses attributed this change mainly to hypertrophy (i.e., increased smooth muscle cell size), we did not determine whether smooth muscle cell numbers were also increased. Our finding that fibroblast numbers seem normal in Pten tm1Hwu/tm1Hwu
;Amhr2 tm3(cre)Bhr/ϩ myometria suggests that the increased thickness of the myometrium was attributable to changes within the smooth muscle cells themselves. Rodent myometrial cells enter a proliferative phase during early pregnancy, and this is thought to be regulated in part by IGF1 signaling via the PI3K/AKT pathway (27) . Therefore, the increased thickness of the myometrium in the Pten tm1Hwu/tm1Hwu ;Amhr2 tm3(cre)Bhr/ϩ uterus before pregnancy suggests that PTEN normally functions to limit muscular development of the nongravid uterus. Whether it is also required during other phases of myometrial development (such as postpartum involution) remains to be determined. Interestingly, uterine muscle fiber development in Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mice also seemed perturbed, as suggested by abnormal TAGLN and ACTA2 immunostaining patterns. Although the reason for this is unclear, rodent myometrial cells normally undergo synthetic and contractile developmental phases following their proliferation phase in early pregnancy, during which contractile proteins are synthesized in preparation for parturition (27) . Thus it would appear that sustained PI3K/AKT signaling caused by PTEN loss interferes with the later stages of myometrial development during pregnancy, leading to the development of cells with poorly organized muscle fibers. Increased myometrial thickness may therefore not result in increased effective uterine contractile ability, as evidenced by dystocia and the failure to expel the fetal remnants and uterine contents in Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mice during the second gestation. In summary, this study demonstrates that PTEN acts in several uterine cell types to regulate critical physiological processes, including decidual regression, trophoblast invasion, maternal vascular remodeling, and epithelial and myometrial proliferation and development. These results confirm and expand the roles played by uterine PI3K/AKT signaling during gestation. We propose that the Pten tm1Hwu/tm1Hwu ; Amhr2 tm3(cre)Bhr/ϩ mouse represents a novel experimental model that will be useful in elucidating the signaling mechanisms that regulate implantation.
